buy cheap toms shoes online,toms sale in usa texas

buy cheap toms shoes online buy,toms sale in usa yahoo ,buy cheap toms shoes online germany,toms sale in valencia ,buy cheap toms shoes online greece,toms sale in valencia 2016 ,buy cheap toms shoes online malaysia,toms sale in valencia 2016 13 ,buy cheap toms shoes online qatar,toms sale in valencia 2016 14 ,buy cheap toms shoes online quantity,toms sale in valencia 2016 kadrosu ,buy cheap toms shoes online yepme,toms sale in valencia 2016 moto2 ,buy cheap toms shoes review,toms sale in valencia 2016 motogp ,buy cheap toms shoes review australia,toms sale in valencia 2016 review ,buy cheap toms shoes review canada,toms sale in valencia 2016 specification ,buy cheap toms shoes review hiking,toms sale in valencia 2016 specifications ,buy cheap toms shoes review india,toms sale in valencia 2016 squad ,buy cheap toms shoes review isaac,toms sale in valencia bukidnon ,buy cheap toms shoes review podiatrist,toms sale in valencia ca ,buy cheap toms shoes review quality,toms sale in valencia ca 91355 ,

Small pharmaceutical companies in order to get drug batch, take risks, and third-party test agencies blending, modify test data. Cost of a bioequivalence study of $ 300,000 to $ 600,000 for some small hospitals, pharmaceutical companies likely to compromise on the data tricks, even the number of trial subjects are even less. Companies to report drug evaluation department is often good-looking data, therefore, 'never heard of bioequivalence test failures, public reports are one-time success.' Shanghai Food and Drug Inspection, deputy director of pharmacists Xie Mu wind told the 'Financial' reporter, as a trusted third party bioequivalence test results on regulations, regulators generally will not be reviewed for review. If the listing and supervision low standard, most companies naturally will be implemented in accordance with the minimum standards of production, can be reduced as much as possible to cut costs. Xie Mu Feng said: 'requires 20 minutes can pass, enterprises are generally considered to achieve 21 minutes can be, do you think it is more than a waste.' Anterior pharmaceutical companies for Chinese generic pharmaceutical companies, the big factor in the decision of its existence the degree of efficacy of the drug is not, and rely on the relationship with the hospital. However, once the efficacy has been put on the regulatory agenda, also it means that the phase-out of low-end imitation of life and death come. In fact, for countries, generic drugs are indispensable. US generics Association (The Generic Pharmaceutical Association) report shows that in 2013 generic drugs to the United States health system savings of up to $ 239 billion in funding, this data has not been the brand-name drug companies face generic competition when the cost of discounts and other considerations that may occur fall included. From a public policy perspective, the generic drugs so that people can get relatively cheaper drugs to reduce Medicare spending. However, the market research company IMS Health Commentator article said, according to the experience of the international market, the price of generic drugs lower, will remain at the original inquest price about 30%. Unfortunately, the current Chinese prices of generic drugs is only 10% of the originator drug. Ultra-low prices so that enterprises have to compromise on quality. Compression Chinese pharmaceutical companies profits are holding the right medication to the hospital. He said the pharmaceutical industry veteran, said the circulation of drugs in the hospital in a strong position, pharmaceutical companies do not have bargaining power,